Results

eNauka >  Results >  Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
Naziv: Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
Autori : Mistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18)
Godina: 2021
Publikacija: AMERICAN JOURNAL OF HEMATOLOGY
ISSN: 0361-8609 American Journal of Hematology Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 96 br. 9 str. 1156-1165
DOI: 10.1002/ajh.26276
WoS-ID: 000671766100001
Scopus-ID: 2-s2.0-85109414235
PMID: 34161616
PMCID: PMC8457136
URI: https://enauka.gov.rs/handle/123456789/826867
Projekat: Sanofi GenzymeSanofi-AventisGenzyme Corporation
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21aM21a - Vodeći međunarodni časopis kategorije M21a

41
SCOPUSTM
22
PubMed CentralTM
9
OpenCitations
37
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.